Medpace Holdings Inc (MEDP) is a Healthcare · Diagnostics & Research company listed on NASDAQ. Price $612.33 (-0.46%), Market cap $11.99B, P/E ratio 26.43, 52-week low–high $293.03 ~ $620.59.
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offer
Financial statements, price targets, institutional (13F) holdings and related news for Medpace Holdings Inc are updated in real time on BlackAll Trade.
Medpace Holdings Inc trades at $612.33 (-0.46%). Real-time quotes and charts are available on BlackAll Trade.
Medpace Holdings Inc has a market cap of about $11.99B. Its P/E ratio is 26.43.
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of